Asset Details
Do you wish to reserve the book?
Microbubbles combined with ultrasound therapy in ischemic stroke: A systematic review of in-vivo preclinical studies
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Microbubbles combined with ultrasound therapy in ischemic stroke: A systematic review of in-vivo preclinical studies
Do you wish to request the book?
Microbubbles combined with ultrasound therapy in ischemic stroke: A systematic review of in-vivo preclinical studies
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Microbubbles combined with ultrasound therapy in ischemic stroke: A systematic review of in-vivo preclinical studies
2018
Overview
Microbubbles (MBs) combined with ultrasound sonothrombolysis (STL) appears to be an alternative therapeutic strategy for acute ischemic stroke (IS), but clinical results remain controversial.
The aim of this systematic review is to identify the parameters tested; to assess evidence on the safety and efficacy on preclinical data on STL; and to assess the validity and publication bias.
Pubmed® and Web of ScienceTM databases were systematically searched from January 1995 to April 2017 in French and English. We included studies evaluating STL on animal stroke model. This systematic review was conducted in accordance with the PRISMA guidelines. Data were extracted following a pre-defined schedule by two of the authors. The CAMARADES criteria were used for quality assessment. A narrative synthesis was conducted.
Sixteen studies met the inclusion criteria. The result showed that ultrasound parameters and types of MBs were heterogeneous among studies. Numerous positive outcomes on efficacy were found, but only four studies demonstrated superiority of STL versus recombinant tissue-type plasminogen activator on clinical criteria. Data available on safety are limited.
Quality assessment of the studies reviewed revealed a number of biases.
Further in vivo studies are needed to demonstrate a better efficacy and safety of STL compared to currently approved therapeutic options.
http://syrf.org.uk/protocols/.
Publisher
Public Library of Science,Public Library of Science (PLoS)
